| Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy (NCT07336797) | Abdelrahman Mahmoud | 2025-09-01 |
| Study of CM313 in Subject With IgA Nephropathy (NCT06830395) | Keymed Biosciences Co.Ltd | 2025-09-01 |
| Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer (NCT07152067) | Centre Hospitalier Universitaire de Liege | 2025-09-01 |
| Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer (NCT05067257) | Sorrento Therapeutics, Inc. | 2025-09-01 |
| CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias (NCT07073742) | Charles University, Czech Republic | 2025-09-01 |
| Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma (NCT07300488) | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2025-09-01 |
| CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation (NCT07117305) | Zhengzhou University | 2025-09-01 |
| Effects of Different Administration Routes of Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Thyroidectomy (NCT07622355) | The Second People's Hospital of Huai'an | 2025-09-01 |
| Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT07572669) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2025-09-01 |
| A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer (NCT04381130) | Everfront Biotech Co., Ltd. | 2025-09-01 |
| Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors (NCT07337421) | Northern Jiangsu People's Hospital | 2025-09-01 |
| Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the Esophageal (NCT07155122) | Fujian Cancer Hospital | 2025-09-01 |
| Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort (NCT06967428) | Independent Medical Alliance | 2025-09-01 |
| A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection (NCT07142200) | RenJi Hospital | 2025-09-01 |
| Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. (NCT07133763) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy. (NCT06973525) | Hebei Medical University Fourth Hospital | 2025-09-01 |
| Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers (NCT07097064) | Institut du Cancer de Montpellier - Val d'Aurelle | 2025-09-01 |
| Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management (NCT06996561) | Dr. Asma Abdus Salam | 2025-09-01 |
| Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial (NCT07050524) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection (NCT07108855) | University Medical Center Groningen | 2025-09-01 |
| The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies (NCT07020260) | Princess Maxima Center for Pediatric Oncology | 2025-09-01 |
| Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients (NCT07101159) | Fujian Cancer Hospital | 2025-09-01 |
| A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC (NCT07040644) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-09-01 |
| A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections. (NCT06948461) | PharmaPlanter Technologies Inc | 2025-09-01 |
| Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care (NCT07096934) | FibroBiologics | 2025-09-01 |
| A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence (NCT06247241) | Versameb AG | 2025-09-01 |
| PDE5 Inhibitor for Alzheimer's Disease (NCT07172815) | Imperial College London | 2025-09-01 |
| Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma (NCT07131345) | National Cancer Center, China | 2025-09-01 |
| Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis (NCT05539625) | University of Edinburgh | 2025-09-01 |
| Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke (NCT07406971) | Instituto Mexicano del Seguro Social | 2025-09-01 |
| Efficacy of Topical Atropine Eye Drops for Control of Myopia Progression Among Children Attending Mansoura University Ophthalmic Center (NCT07164092) | Mansoura University | 2025-09-01 |
| Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial (NCT06854224) | Marianne Goodman | 2025-09-01 |
| Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation (NCT06981338) | Institut Guttmann | 2025-09-01 |
| UBT251 Injection Phase II Clinical Study (CKD) (NCT07134335) | The United Bio-Technology (Hengqin) Co., Ltd. | 2025-09-01 |
| Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML (NCT07304232) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-01 |
| Linperlisib in the Treatment of aPRCA (NCT07031115) | Peking Union Medical College Hospital | 2025-09-01 |
| Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus (NCT07083882) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2025-09-01 |
| COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis (NCT06726707) | Hospital Israelita Albert Einstein | 2025-09-01 |
| Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features (NCT06506136) | Zhifeng Zhao, PhD | 2025-09-01 |
| NG2 and DLL3 CAR-T Cells Targeting Melanoma (NCT07193966) | Shenzhen Geno-Immune Medical Institute | 2025-09-01 |
| Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer (NCT06951399) | Rabin Medical Center | 2025-09-01 |
| Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS) (NCT06040476) | StemCyte, Inc. | 2025-09-01 |
| A-TANGO Phase 2 Study (NCT06890039) | Yaqrit Ltd | 2025-09-01 |
| Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) (NCT07432399) | Institute of Oncology Ljubljana | 2025-09-01 |
| Neuromodulation in Patients With Pulmonary Arterial Hypertension (NCT06802380) | University of Oklahoma | 2025-09-01 |
| SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer (NCT07109284) | West China Hospital | 2025-09-01 |
| The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment (NCT07395960) | Fudan University | 2025-09-01 |
| Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy (NCT07151326) | National Health Research Institutes, Taiwan | 2025-09-01 |
| T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis (NCT07150208) | Fudan University | 2025-09-01 |
| Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study. (NCT06646445) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2025-09-01 |
| Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma (NCT07135804) | Second Affiliated Hospital of Nanchang University | 2025-09-01 |
| Trifecta Research Study (NCT06810765) | Johns Hopkins University | 2025-09-01 |
| Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma (NCT07144657) | National Taiwan University Hospital | 2025-09-01 |
| Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer. (NCT07136974) | Henan Cancer Hospital | 2025-09-01 |
| Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases. (NCT07133776) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia (NCT07512700) | Chinese PLA General Hospital | 2025-09-01 |
| A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma (NCT07128693) | The First Affiliated Hospital of Zhengzhou University | 2025-09-01 |
| Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer (NCT07184021) | Assiut University | 2025-09-01 |
| Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. (NCT07147088) | Fudan University | 2025-09-01 |
| A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer (NCT07173556) | Qilu Pharmaceutical Co., Ltd. | 2025-09-01 |
| Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment (NCT07171723) | University Hospital, Gentofte, Copenhagen | 2025-09-01 |
| Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) (NCT05633446) | Gylden Pharma Ltd | 2025-09-01 |
| Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL (NCT06930105) | Xianmin Song, MD | 2025-09-01 |
| Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT07044349) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2025-09-01 |
| Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma (NCT06933966) | Centre Leon Berard | 2025-09-01 |
| Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia (NCT07321301) | Daihong Liu | 2025-09-01 |
| Autologous Cold-stored Apheresis Platelets (NCT07064954) | University Health Network, Toronto | 2025-09-01 |
| Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain (NCT07159243) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-09-01 |
| Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer (NCT07153965) | Tianjin Medical University Cancer Institute and Hospital | 2025-09-01 |
| Evaluation of Lymphatic Response to Physiotherapy in Patients With Swelling Associated With Superficial Venous Disease (NCT07165340) | The University of Texas Health Science Center, Houston | 2025-09-01 |
| Amino Acids for Cardiac Surgery Associated AKI (NCT07001098) | Stanford University | 2025-09-01 |
| Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy (NCT07164690) | Fudan University | 2025-09-01 |
| High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy (NCT07213375) | Rigshospitalet, Denmark | 2025-09-01 |
| Digoxin and Senolysis in Heart Failure and Diabetes Mellitus (NCT06240403) | University of Leeds | 2025-09-01 |
| A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer (NCT07123441) | Sanjun Cai | 2025-09-01 |
| A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. (NCT06886139) | Zhejiang Teruisi Pharmaceutical Inc. | 2025-09-01 |
| Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy (NCT07192848) | Song Peng | 2025-09-01 |
| Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer (NCT07718490) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer (SMARTi-RC01) (NCT07134101) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation (NCT07025824) | Technische Universität Dresden | 2025-09-01 |
| 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer. (NCT06335069) | Maastricht University Medical Center | 2025-09-01 |
| Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer (NCT06561308) | Women's Hospital School Of Medicine Zhejiang University | 2025-09-01 |
| Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy (NCT07131033) | The Second People's Hospital of Huai'an | 2025-09-01 |
| Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room (NCT05057689) | Nationwide Children's Hospital | 2025-09-01 |
| Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. (NCT06296745) | Guangzhou Medical University | 2025-09-01 |
| Testing Interventions for Borderline Personality Disorder. (NCT06458933) | York University | 2025-09-01 |
| Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) (NCT06097481) | University of Colorado, Denver | 2025-09-01 |
| The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multicenter, Phase II Clinical Study (NCT07240194) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients (NCT06432166) | MTI Biotech Inc | 2025-09-01 |
| A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys (NCT06582485) | iCoat Medical AB | 2025-09-01 |
| Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer (NCT07151872) | Qilu Pharmaceutical Co., Ltd. | 2025-09-01 |
| Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome (NCT07079696) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-09-01 |
| MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. (NCT05888857) | Institut Bergonié | 2025-09-01 |
| Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy (NCT07145268) | Tanta University | 2025-09-01 |
| Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma. (NCT07266480) | Hebei Medical University Fourth Hospital | 2025-09-01 |
| A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy (NCT07069270) | Fujian Cancer Hospital | 2025-09-01 |
| Remineralization Effect Of Egg Shell Versus Fluoride Varnish On Early Carious White Spot Lesions In Primary Teeth (NCT06932926) | Cairo University | 2025-09-01 |
| Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms (NCT07105267) | Assistance Publique - Hôpitaux de Paris | 2025-09-01 |
| Efficacy of SALI-10 Oral Probiotics in Experimental Gingivitis (NCT07256743) | Ostia Sciences | 2025-09-01 |
| A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors (NCT07124793) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-08-31 |